SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-023265
Filing Date
2020-05-08
Accepted
2020-05-08 09:06:21
Documents
56
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-10q_20200331.htm 10-Q 1195170
2 EX-31.1 crnx-ex311_8.htm EX-31.1 21620
3 EX-31.2 crnx-ex312_7.htm EX-31.2 21573
4 EX-32.1 crnx-ex321_6.htm EX-32.1 7033
  Complete submission text file 0001564590-20-023265.txt   5001715

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT crnx-20200331.xml EX-101.INS 1113660
6 XBRL TAXONOMY EXTENSION SCHEMA crnx-20200331.xsd EX-101.SCH 37201
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE crnx-20200331_cal.xml EX-101.CAL 40407
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE crnx-20200331_def.xml EX-101.DEF 112191
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE crnx-20200331_lab.xml EX-101.LAB 330262
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crnx-20200331_pre.xml EX-101.PRE 243814
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 20858942
SIC: 2834 Pharmaceutical Preparations